Detailed Information
Cited 0 time in 
Cited 11 time in 
Cited 11 time in
Metadata Downloads
Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
- Authors
- Kim H.R.; Lee Y.S.; Yim H.J.; Lee H.J.; Ryu J.Y.; Lee H.J.; Yoon E.L.; Lee S.J.; Hyun J.J.; Jung S.W.; Koo J.S.; Choung R.S.; Lee S.W.; Choi J.H.
- Issue Date
- 2013
- Keywords
- Terlipressin; Necrosis; Hepatorenal syndrome
- Citation
- Clinical and molecular hepatology, v.19, no.4, pp 417 - 420
- Pages
- 4
- Indexed
- SCOPUS
KCI
- Journal Title
- Clinical and molecular hepatology
- Volume
- 19
- Number
- 4
- Start Page
- 417
- End Page
- 420
- ISSN
- 2287-2728
2287-285X
- Abstract
- Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious complications such as myocardial infarction, skin necrosis, or bowel ischemia. Herein we report a case of severe ischemic bowel necrosis in a 46-year-old cirrhotic patient treated with terlipressin. Although the patient received bowel resection, death occurred due to ongoing hypotension and metabolic acidosis. Attention should be paid to patients complaining of abdominal pain during treatment with terlipressin.
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Yim, Hyung Joon
- Ansan Hospital (Department of Gastroenterology and Hepatology, Ansan Hospital)